S, Z., S, C., G, C., Y, S., Y, B., S, P., . . . J, H. (2026). Surgical margin assessment after neoadjuvant chemotherapy plus nimotuzumab in locally advanced oral squamous cell carcinoma. Journal of the Chinese Medical Association : JCMA, 89(1), 90. https://doi.org/10.1097/JCMA.0000000000001199
Chicago Style (17th ed.) CitationS, Zhang, Chen S, Chai G, Shi Y, Bao Y, Peng S, Cui Z, and Hao J. "Surgical Margin Assessment After Neoadjuvant Chemotherapy Plus Nimotuzumab in Locally Advanced Oral Squamous Cell Carcinoma." Journal of the Chinese Medical Association : JCMA 89, no. 1 (2026): 90. https://doi.org/10.1097/JCMA.0000000000001199.
MLA (9th ed.) CitationS, Zhang, et al. "Surgical Margin Assessment After Neoadjuvant Chemotherapy Plus Nimotuzumab in Locally Advanced Oral Squamous Cell Carcinoma." Journal of the Chinese Medical Association : JCMA, vol. 89, no. 1, 2026, p. 90, https://doi.org/10.1097/JCMA.0000000000001199.